Telix Pharmaceuticals Limited Interest Expense
Telix Pharmaceuticals Limited (TLPPF) reported Interest Expense of $181.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-02-20
AUD
| Period end | Interest Expense 12 month |
|---|---|
| 2024-12-31 | 82.00K AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 148.00K AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 46.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | $181.00K 20-F · filed 2026-02-20 |
| 2024-12-31 | $64.00K 20-F · filed 2026-02-20 |
| 2023-12-31 | $97.00K 20-F · filed 2026-02-20 |